Dalrada (DFCO) Removes Shell Company Status.
LIVE QUOTE
SAN DIEGO, Nov. 6, 2020
SAN DIEGO , Nov. 6, 2020 /PRNewswire/ -- Dalrada Financial Corp. (OTC Pink: DFCO), announced that it has filed Form 8-A12b with the U.S....
Dalrada (DFCO) Announces Form S-1 Registration Declared Effective by SEC
SAN DIEGO , Nov. 3, 2020 /PRNewswire/ -- Dalrada Financial Corp. (OTC Pink: DFCO), is pleased to announce that its Form S-1 registration statement has been declared effective by...
Hapbee Technologies (HAPB): Updates and News Archive.
Recent Headlines
UPDATED CONTINUOUSLY.
June 4, 2021: Hapbee (HAPBF) Selects Accomplished Technology and Consumer Products Entrepreneur & Executive as CEO.
May 27, 2021: Adding Hapbee Tech (HAPB,...
Hapbee (HAPB) Soars 136% the First Day of Trading!
LIVE QUOTE
Subscribe here for upcoming report.
Investors who participated in the recently closed Hapbee Technologies (HAPB) private placement in July at CDN $0.30 per share...
Telehealth App Hapbee (HAPB) Goes Public and More.
1. Hapbee (HAPB) $0.30, Going Public.2. Saying Goodbye to Immunomedics (IMMU) $86.3. Adding Biosig (BSGM) $2.95, to Watch List.4. Dalrada (DFCO) $0.11, Cancer Screening Test...
Hapbee (HAPB) to Commence Trading on the TSX Venture Exchange.
VANCOUVER, BC, Oct. 28, 2020 /CNW/ - Hapbee Technologies, Inc. (TSXV: HAPB) ("Hapbee" or the "Company"), a wellness technology company developing the revolutionary Hapbee...
Dalrada Cervical Cancer Testing Kit Study.
KEY TAKEAWAYS
Dalrada Corp (DFCO)
LIVE QUOTE
This was admittedly a small test, with only 100 patients. But keep in mind in the first place, this isn't...
Dalrada’s ‘VIA’ Test Screening Kit Goes Head to Head with ‘Pap’ Smear Test Screening.
DALRADA aims to introduce its VIA Test kit to females in India - of which there is 497 million.
https://youtu.be/fXwvdN4XnKU
In 2012, the U.S. Preventive...
Citius Pharma (CTXR) Shareholder Letter | Year Ahead Roadmap.
2021 and 2020 Milestones In Plain Sight.
Locked and Loaded for most of 2020 - many major milestone events lie around the corner for Citius...















